BASP1P1: A Potential Drug Target and Biomarker (G646201)

Target Name: BASP1P1

NCBI ID: G646201

BASP1P1

Other Name(s): BASP1 pseudogene 1

BASP1P1: A Potential Drug Target and Biomarker

The Basal and family

The basal family are a family of proteins that play a crucial role in cell signaling pathways. These proteins are involved in a wide range of cellular processes, including cell adhesion, migration, and invasion. The basal family is composed of four subfamilies: BASP1, BASP2, BASP3, and BASP4. In this article, we will focus on the protein BASP1P1, also known as BASP1 pseudogene 1.

BASP1P1: Structure and Function

BASP1P1 is a 21-kDa protein that is expressed in various tissues, including brain, heart, liver, and pancreas. It is a member of the BASP1 family and is responsible for the production of a variety of signaling molecules, including the neurotransmitterInsertive.

The BASP1P1 protein has a molecular weight of 21 kDa and a calculated pI of 7.4. It has four known isoforms, which are different in their size and function. The most abundant is the N-terminal isoform, which contains 115 amino acids. The second -most abundant is the C-terminal isoform, which contains 112 amino acids. The third is the middle isoform, which contains 99 amino acids, and the fourth is the C-terminal isoform, which contains 98 amino acids.

BASP1P1 is involved in several cellular processes, including cell adhesion, migration, and invasion. It plays a key role in the regulation of cell-cell adhesion by participating in the cadherin/basal family signaling pathway. This pathway is involved in the maintenance of tissue structure and in the development and maintenance of various tissues, including organs and tissues.

BASP1P1 has also been shown to be involved in the regulation of cell migration and invasion. It has been shown to promote the migration of cancer cells and to contribute to the invasive properties of these cells. This suggests that BASP1P1 may be a potential drug target for cancer therapies.

BASP1P1 has also been shown to play a role in the regulation of neurotransmitter synthesis and release. It is a key regulator of the synthesis and release of the neurotransmitterInsertive, which is involved in the regulation of neurotransmission.

BASP1P1 and Disease

BASP1P1 has been implicated in the development and progression of several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

One of the leading theories about the role of BASP1P1 in cancer is that it contributes to the regulation of cell proliferation and survival. This is consistent with the known functions of BASP1P1, including the regulation of cell adhesion and the production of signaling molecules involved in cell proliferation.

BASP1P1 has also been shown to be involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. These diseases are characterized by the progressive loss of brain cells and can lead to a wide range of symptoms, including cognitive decline and motor dysfunction.

BASP1P1 has also been implicated in the development and progression of autoimmune diseases, including rheumatoid arthritis and multiple sclerosis. These diseases are characterized by the immune system attacking the body's own tissues, leading to inflammation and damage.

BASP1P1 Targeting

BASP1P1 is a potential drug target and biomarker for a variety of diseases. Targeting BASP1P1 with small molecules or antibodies has been shown to be effective in a variety of experimental models, including cancer, neurodegenerative diseases, and autoimmune diseases.

One approach to targeting BASP1P1 is to use small molecules that can inhibit its activity.

Protein Name: BASP1 Pseudogene 1

The "BASP1P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BASP1P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets